Aspirin (ASA), a nonsteroidal anti-inflammatory drug (NSAID), has proven chemopreventive benefits in LS, with the CAPP2 randomized double-blind placebo-controlled trial demonstrating a 60% relative ...

and a combination of aspirin plus extended-release dipyridamole (ASA-ERDP). Combinations of these three therapies are not used widely. Previous studies have demonstrated that ASA-ERDP and ...

Triple therapy was a combination of aspirin, thienopyridine and warfarin. ACS: Acute coronary syndrome; AF: Atrial fibrillation; Asa: Aspirin; BMS: Bare-metal stent ...

It is also referred to as acetylsalicylic acid (ASA) and salicylic acid. Aspirin has a very short half-life, meaning it is ...

to prevent nasal polyps and subsequent aspirin sensitive asthma successfully. The author has been using ASA at low dosages since 1985 after testing for thrombocyte hyperaggregability (2).